← back to search

Siqi Gao

Zhejiang Chinese Medical University · CN
Area of research
Molecular Biology · Hepatology
Research interest
Research interests include CRISPR and Genetic Engineering, Liver physiology and pathology, Advanced biosensing and bioanalysis techniques, and Cell death mechanisms and regulation.
h-index
21
citations
1,299
works
96
NIH funding
primary concept
email

Recent publications

Olink proteomics reveals TNFRSF9 as a biomarker for abdominal aortic aneurysms
iScience 2025cited by 4position: middledoi
Diet in China during substantial economic growth: Quality, inequality, trends, and determinants
China Economic Review 2024cited by 9position: firstdoi
Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
Frontiers in Pharmacology 2024cited by 8position: middledoi
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice
Stroke 2023cited by 21position: middledoi
Diet in China During Substantial Economic Growth: Quality, Inequality, Trends, and Determinants
SSRN Electronic Journal 2023cited by 0position: firstdoi
Closely related type II-C Cas9 orthologs recognize diverse PAMs
eLife 2022cited by 38position: middledoi
Synaptic Secretion and Beyond: Targeting Synapse and Neurotransmitters to Treat Neurodegenerative Diseases
Oxidative Medicine and Cellular Longevity 2022cited by 21position: middledoi
Quantification of carbohydrates in human serum using gas chromatography–mass spectrometry with the stable isotope-labeled internal standard method
New Journal of Chemistry 2022cited by 4position: middledoi
E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis
Cell Death and Differentiation 2021cited by 78position: middledoi
Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity
Nucleic Acids Research 2021cited by 63position: middledoi
Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
Journal of Translational Medicine 2021cited by 29position: middledoi
Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease
Frontiers in Cell and Developmental Biology 2020cited by 49position: middledoi
Structural Basis of Human Helicase DDX21 in RNA Binding, Unwinding, and Antiviral Signal Activation
Advanced Science 2020cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yongming Wang · Fudan University5 papers (2020–2022)Tao Qi · Fudan University3 papers (2020–2022)Jixi Li · Fudan University3 papers (2020–2021)Lizheng Li · Shanxi Medical University2 papers (2024–2025)Linghui Hou · Fudan University2 papers (2021–2022)Honglin Dong · Shanxi Medical University2 papers (2024–2025)Miaomiao Li · New York University2 papers (2020–2021)Chen Ding · Beijing University of Chemical Technology2 papers (2020–2021)Jingjing Wei · Fudan University2 papers (2021–2022)Feiyan Xie · Fudan University2 papers (2020–2021)Feng Lan · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2021)Xiangjun Chen · Fudan University2 papers (2020–2021)Ming‐Jia Zhang · Harbin Medical University1 papers (2022–2022)Maolin Qiao · Shanxi Medical University1 papers (2025–2025)Ziwen Wang · Sun Yat-sen University1 papers (2022–2022)Jingtong Liu · Fudan University1 papers (2022–2022)Shijun Hu · Central South University1 papers (2021–2021)Keyi Fan · Shanxi Medical University1 papers (2025–2025)Jianhua Gan · Fudan University1 papers (2020–2020)Zhen‐Ao Zhao · Hebei Medical University1 papers (2021–2021)